Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Centrus Is Down 69% From Its High. Is Its $4.5 Billion Backlog Enough to Buy at $143?

The nuclear energy company faces daunting near-term challenges.

Centrus Is Down 69% From Its High. Is Its $4.5 Billion Backlog Enough to Buy at $143?

Published October 11, 2026 · Category: Finance

Overview

Centrus Energy's (NYSE: LEU) stock closed at a 52-week high of $464.25 per share on Oct. 16, 2025. Today, it trades at about $143. Let's see why this nuclear energy stock shed 69% of its value -- and if its growing backlog makes it a contrarian investment today.

Centrus is one of the few U.S. companies licensed to sell low-enriched uranium (LEU), the most commonly used fuel in commercial nuclear reactors. It's also the only public U.S. company that produces high-assay low-enriched uranium (HALEU) for next-gen nuclear reactors.

Image source: Getty Images.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.